Azelis to Distribute Angus’ Portfolio of Nitroalkanes in Europe

Angus Chemical Company announced an arrangement with Azelis as part of its new distribution strategy for the company’s complete portfolio of nitroalkanes and their derivatives sold in Europe. The Belgian specialty chemicals distributor has been appointed as a distribution partner, effective Jan. 1, 2017. The partnership includes the biotechnology market on a pan-European basis (including Turkey, and excluding Finland, Lithuania, Latvia and Estonia until April 1, 2017) and paints, coatings and other industrial markets for France, Belgium, The Netherlands and Luxembourg.

“We look forward to the technical expertise and logistics capabilities the Azelis team brings to delivering the products and support our Life Sciences customers need on a pan-European basis, while providing a more focused geographical approach for customers in specific paints and coatings, and other industrial markets,” said Liam Doherty, business vice president, EMEA and India.

Matthew Dickman, Azelis’ market segment director Pharma, added: “Angus and Azelis Pharma share the same focus on delivering market-specific solutions and expertise. The partnership will enable both parties to focus on providing the highest level of technical, logistical and customer service support to the growing customer base across Europe and Turkey. We are delighted to partner with Angus for this strategic business, utilising the extensive network of Azelis and the unrivalled technical and product experience of Angus to drive growth and innovation for our customers.”

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.